ClinicalTrials.Veeva

Menu

The Safety and Feasibility of MONOFIX on Fascial Closure of Mid-line Wound After Minimally Invasive Colorectal Cancer Surgery

Samsung Medical Center logo

Samsung Medical Center

Status

Completed

Conditions

Rectal Adenocarcinoma
Colon Cancer
Colon Adenocarcinoma
Rectal Cancer

Treatments

Device: Monofix

Study type

Interventional

Funder types

Other

Identifiers

NCT05872334
MONOFIX_01

Details and patient eligibility

About

This clinical trial aims to evaluate the safety and feasibility of mid-line fascial suturing using MONOFIX sutures in patients undergoing minimally invasive surgery for colorectal cancer.

Enrollment

120 patients

Sex

All

Ages

18 to 80 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Colorectal adenocarcinoma
  • Elective (or planned) curative surgery
  • Laparoscopic surgery
  • Midline incision less than 10 cm

Exclusion criteria

  • Previous laparotomy with midline incision more than 10cm.
  • Systemic chemotherapy for any cause within the last 6 months.

Trial design

Primary purpose

Prevention

Allocation

Non-Randomized

Interventional model

Single Group Assignment

Masking

Single Blind

120 participants in 2 patient groups

Monofix
Experimental group
Description:
In patients who underwent laparoscopic colorectal cancer surgery, the fascial closure of the midline incision was performed using a running suture type with Monofix, one of the barbed sutures.
Treatment:
Device: Monofix
Control group
No Intervention group
Description:
In patients who underwent laparoscopic colorectal cancer surgery, the fascial closure of the midline incision was performed using an interrupted suture type with PDS-II, one of the monofilament sutures.

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems